-
NMPA Issues Three Guidances including the Guidance for Nomenclature for Generic Names of Medical Imaging Devices
2020-06-30
NMPA has organized to formulate the Guidance for Nomenclature for Generic Names of Medical Imaging Devices, Guidance for Nomenclature for Generic Names of Active Implanted Devices and Guidance for Nomenclature for Generic Names of Dental Instruments, which are issued on June 22, 2020.
-
NMPA Revises Package Insert of Docusate Sodium and Dantron Capsules
2020-05-22
On May 22, 2020, NMPA issued an Announcement with decisions made to revise the [adverse reactions], [precautions], etc. in the package insert of Docusate Sodium and Dantron Capsules.
-
NMPA Issues the Announcement on 6 Technical Review Guidances for Registration Including the Technical Review Guidance for the Registration of Disposable Breast localization Wire
2020-07-09
To strengthen the supervision and guidance over medical device registration, and further improve the quality of registration review, NMPA has organized to formulate 6 technical review guidances for registration including the Technical Review Guidance for the Registration of Disposable Breast localization Wire.
-
NMPA Issues the Notice on Matters Related to Further Strengthening Management for Mandatory Industry Standards of Medical Devices
2020-07-09
NMPA issued the notice on matters related to further strengthening management for mandatory industry standards of medical devices.
-
NMPA Issues the Announcement on Three Documents Including the Working Procedures for Review of Breakthrough Therapy Drugs (Interim)
2020-07-07
NMPA has organized to formulate the Working Procedures for Review of Breakthrough Therapy Drugs (Interim), Working Procedures for Review and Approval of Applications for Conditional Approval of Drug Marketing (Interim) and Working Procedures for Priority Review and Approval of Drug Marketing Authorization (Interim).
-
NMPA Issues the Announcement on Implementing the 2020 Edition of the Pharmacopoeia of the People's Republic of China
2020-07-03
The 2020 Edition of the Pharmacopoeia of the People's Republic of China (hereinafter referred to as 2020 Chinese Pharmacopoeia) has been issued by NMPA and NHC Announcement.